为调查了解企业产品和产业现状，把握行业发展趋势，本报告采用问卷调查法和文献分析法，对我国医疗人工智能企业进行调查，并回收数据。本次调查回收问卷51份，有效问卷42份，其中，52.38%为医疗人工智能领域新创公司，33.33%为开展智能化升级的传统医疗信息化企业，其余为跨行业创业企业和其他企业。全国更多省份积极成立医疗人工智能企业；企业研发团队数量没有显著增长；融资企业占比下降，融资金额增加；生成式大模型成为医疗AI技术应用的亮点。建议加快制定医疗人工智能产品服务价格和医保支付政策，分类制定医疗人工智能产品数据管理规范和相关标准，积极探索在医疗服务流程中的产品应用衔接、质量监管和效果评价，完善产业环境、产业生态政策和相关伦理法规，在融资、上市方面给予医疗人工智能企业更多的扶持。
To investigate and understand the current situation of enterprise products and industry，and grasp the development trend of the industry，this report adopts questionnaire survey method and literature analysis method to investigate the medical artificial intelligence enterprises in China and recover the data. The survey recovered 51 questionnaires and 42 valid questionnaires，of which 52.38% were start-ups in the field of medical artificial intelligence，33.33% were traditional medical information technology enterprises carrying out intelligent upgrading，the rest were cross-industry start-ups and other businesses. More provinces across the country are actively setting up medical AI enterprises；there is no significant growth in enterprise R&D teams；the proportion of financed enterprises has decreased，and the amount of financing has risen；and generative large models have become the highlight of medical AI technology applications. It is suggested to accelerate the formulation of medical AI product and service prices and health insurance payment policies；classify and formulate data management norms and relevant standards for medical AI products；actively explore the articulation，quality supervision and effect evaluation in the medical service process；improve the industrial environment，industrial ecological policies and relevant ethical regulations；and give more support to medical AI enterprises in financing and listing.
